Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Porwit

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|August 5, 2020
p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphomaJoana M Rodrigues, May Hassan, Catja Freiburghaus, et al.
Blood|April 10, 2009
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesJames W Vardiman, Jüergen Thiele, Daniel A Arber, et al.
Cytometry. Part B, Clinical Cytometry|February 18, 2022
A series of case studies illustrating the role of flow cytometry in the diagnostic work-up of myelodysplastic syndromesTheresia M Westers, Leonie Saft, Vincent H J van der Velden, et al.
American Journal of Hematology|December 1, 2015
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapyUday Deotare, Karen W L Yee, Lisa W Le, et al.
Oncology Letters|October 5, 2016
Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regionsTherese Högfeldt, Crystal Jaing, Kevin Mc Loughlin, et al.
Haematologica|August 30, 2023
MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and <i>TP53</i>/p53 - a Nordic Lymphoma Group studyJoana M Rodrigues, Peter Hollander, Lina Schmidt, et al.
Blood|January 14, 2011
Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classificationEstella Matutes, Winfried F Pickl, Mars Van't Veer, et al.
Blood Advances|July 3, 2024
CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppressionJoana de Matos Rodrigues, Lavanya Lokhande, Lina M Olsson, et al.
Journal of the National Cancer Institute|February 3, 2005
Ultraviolet radiation exposure and risk of malignant lymphomasKarin Ekström Smedby, Henrik Hjalgrim, Mads Melbye, et al.
Leukemia Research|October 22, 2010
In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemiaGudmar Lönnerholm, Ingrid Thörn, Christer Sundström, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|August 5, 2020
p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphomaJoana M Rodrigues, May Hassan, Catja Freiburghaus, et al.
Blood|April 10, 2009
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesJames W Vardiman, Jüergen Thiele, Daniel A Arber, et al.
Cytometry. Part B, Clinical Cytometry|February 18, 2022
A series of case studies illustrating the role of flow cytometry in the diagnostic work-up of myelodysplastic syndromesTheresia M Westers, Leonie Saft, Vincent H J van der Velden, et al.
American Journal of Hematology|December 1, 2015
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapyUday Deotare, Karen W L Yee, Lisa W Le, et al.
Oncology Letters|October 5, 2016
Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regionsTherese Högfeldt, Crystal Jaing, Kevin Mc Loughlin, et al.
Haematologica|August 30, 2023
MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and <i>TP53</i>/p53 - a Nordic Lymphoma Group studyJoana M Rodrigues, Peter Hollander, Lina Schmidt, et al.
Blood|January 14, 2011
Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classificationEstella Matutes, Winfried F Pickl, Mars Van't Veer, et al.
Blood Advances|July 3, 2024
CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppressionJoana de Matos Rodrigues, Lavanya Lokhande, Lina M Olsson, et al.
Journal of the National Cancer Institute|February 3, 2005
Ultraviolet radiation exposure and risk of malignant lymphomasKarin Ekström Smedby, Henrik Hjalgrim, Mads Melbye, et al.
Leukemia Research|October 22, 2010
In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemiaGudmar Lönnerholm, Ingrid Thörn, Christer Sundström, et al.
Pageof 12